Incannex Healthcare Inc. SEC filings IXHL
Incannex Healthcare Inc. has 266 filings in SEC EDGAR's recent list, going back to Aug 17, 2021. Its latest annual report, Form ARS, was filed on Oct 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 28, 2026 | Jun 30, 2026 |
| DEFA14A | Additional proxy material | Oct 28, 2026 | — |
| DEF 14A | Proxy statement | Oct 28, 2026 | Dec 17, 2026 |
| 10-K | Annual report | Sep 25, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 25, 2026 | Aug 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Mar 17, 2026 | Mar 16, 2026 |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure, Other events
|
Mar 12, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 25, 2026 | Feb 24, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Jan 22, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jan 16, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Other events
|
Jan 15, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| DEFA14A | Additional proxy material | Dec 18, 2025 | — |
| DEFA14A | Additional proxy material | Dec 16, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 14, 2025 |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| ARS | Annual report to shareholders | Oct 27, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Oct 27, 2025 | — |
| DEF 14A | Proxy statement | Oct 27, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 22, 2025 | Oct 21, 2025 |
| 10-K | Annual report | Sep 29, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 26, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Other events
|
Aug 22, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Other events
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 424B5 | Prospectus supplement | Jul 24, 2025 | — |
| S-3MEF | Registration statement | Jul 24, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Other events
|
Jun 12, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Jun 4, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Other events
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 28, 2025 | May 28, 2025 |
| 424B5 | Prospectus supplement | May 28, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 28, 2025 | May 27, 2025 |
| 8-K |
Current report
Other events
|
May 20, 2025 | May 20, 2025 |
| 8-K |
Current report
Other events
|
May 20, 2025 | May 20, 2025 |
| 424B5 | Prospectus supplement | May 20, 2025 | — |
| 8-K |
Current report
Other events
|
May 16, 2025 | May 16, 2025 |
| DEFA14A | Additional proxy material | May 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Material agreement
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Other events
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 14, 2025 | May 14, 2025 |
| UPLOAD | Letter from the SEC | Apr 29, 2025 | — |
| EFFECT | Filing | Apr 28, 2025 | — |
| 424B3 | Prospectus | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | May 27, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 25, 2025 | Apr 23, 2025 |
| CORRESP | Letter to the SEC | Apr 24, 2025 | — |
| PRER14A | Revised preliminary proxy statement | Apr 17, 2025 | — |
| S-1/A | Amended registration statement | Apr 16, 2025 | — |
| CORRESP | Letter to the SEC | Apr 16, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 7, 2025 | Apr 7, 2025 |
| 424B5 | Prospectus supplement | Apr 7, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 3, 2025 | Apr 3, 2025 |
| UPLOAD | Letter from the SEC | Apr 2, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2025 | — |
| S-3 | Shelf registration | Mar 24, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Mar 18, 2025 | Mar 13, 2025 |
| D | Filing | Mar 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 10, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Other events
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 10, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2024 | Dec 11, 2024 |
| EFFECT | Filing | Dec 6, 2024 | — |
| 424B3 | Prospectus | Dec 6, 2024 | — |
| CORRESP | Letter to the SEC | Dec 4, 2024 | — |
| S-1/A | Amended registration statement | Nov 26, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Nov 13, 2024 | — |
| ARS | Annual report to shareholders | Nov 12, 2024 | Jun 30, 2024 |
| DEF 14A | Proxy statement | Nov 12, 2024 | Dec 11, 2024 |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 31, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Oct 24, 2024 | Oct 23, 2024 |
| 3 | Initial insider ownership | Oct 24, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2024 | Oct 21, 2024 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Oct 21, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 15, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 10, 2024 | Sep 9, 2024 |
| RW | Withdrawal request | Sep 10, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2024 | Aug 5, 2024 |
| 5 | Annual insider ownership | Aug 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| S-1/A | Amended registration statement | Jul 17, 2024 | — |
| S-1 | Registration statement | Jul 3, 2024 | — |
| 8-K |
Current report
Other events
|
May 30, 2024 | May 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Other events
|
Apr 16, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Other events
|
Feb 16, 2024 | Feb 16, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Feb 1, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 24, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Other events
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Dec 22, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 21, 2023 |
| S-8 | Employee stock plan registration | Dec 20, 2023 | — |
| 8-K |
Current report
Auditor change
|
Dec 15, 2023 | Dec 14, 2023 |
| 3/A | Filing | Dec 8, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 28, 2023 |
| EFFECT | Filing | Nov 30, 2023 | — |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Nov 29, 2023 | Nov 28, 2023 |
| POS AM | Post-effective amendment no. 1 to form f-3 | Nov 29, 2023 | — |
| 15-12G | Deregistration | Nov 29, 2023 | — |
| 25-NSE/A | Filing | Nov 29, 2023 | — |
| 25-NSE | Delisting notice | Nov 28, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 24, 2023 | Nov 23, 2023 |
| 6-K | Current report (foreign issuer) | Nov 20, 2023 | Nov 17, 2023 |
| 6-K | Current report (foreign issuer) | Nov 17, 2023 | Nov 17, 2023 |
| 6-K | Current report (foreign issuer) | Nov 17, 2023 | Nov 17, 2023 |
| 6-K | Current report (foreign issuer) | Nov 16, 2023 | Nov 16, 2023 |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Nov 7, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 26, 2023 | Oct 26, 2023 |
| 6-K | Current report (foreign issuer) | Oct 19, 2023 | Oct 19, 2023 |
| 6-K | Current report (foreign issuer) | Oct 10, 2023 | Oct 10, 2023 |
| 6-K | Current report (foreign issuer) | Oct 5, 2023 | Oct 5, 2023 |
| 6-K | Current report (foreign issuer) | Sep 8, 2023 | Sep 8, 2023 |
| 6-K | Current report (foreign issuer) | Sep 1, 2023 | Sep 1, 2023 |
| 6-K | Current report (foreign issuer) | Sep 1, 2023 | Aug 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 24, 2023 | Aug 24, 2023 |
| 6-K | Current report (foreign issuer) | Aug 22, 2023 | Aug 22, 2023 |
| 6-K | Current report (foreign issuer) | Aug 10, 2023 | Aug 10, 2023 |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Aug 1, 2023 | Aug 1, 2023 |
| 6-K | Current report (foreign issuer) | Jul 28, 2023 | Jul 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 26, 2023 | Jul 26, 2023 |
| 6-K | Current report (foreign issuer) | Jul 21, 2023 | Jul 21, 2023 |
| 6-K | Current report (foreign issuer) | Jul 18, 2023 | Jul 18, 2023 |
| 6-K | Current report (foreign issuer) | Jul 13, 2023 | Jul 13, 2023 |
| 6-K | Current report (foreign issuer) | Jul 10, 2023 | Jul 10, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 6, 2023 |
| 6-K | Current report (foreign issuer) | Jun 30, 2023 | Jun 30, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IXHL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Norwest Nsw
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1873875
- Former names
- Incannex Healthcare Ltd (until Nov 29, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.